Trials / Withdrawn
WithdrawnNCT05065164
Denosumab and Screw Fixation for Osteoporotic Compression Fracture
Attending Doctor of Shenzhen People's Hospital
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Shenzhen People's Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of bone mineral density and function at 1 year after screw internal fixation of osteoporotic vertebral compression fractures with desuzumab: a parallel double-blind randomized controlled clinical trial
Detailed description
Conduct a single-center, double-blind, randomized controlled clinical trial according to clinical Trial Reporting Standards (CONSORT). Bone mineral density and function were compared 1 year after screw internal fixation of osteoporotic vertebral compression fracture (OVCF) with desomumab versus placebo in Shenzhen People's Hospital from September, 2021 to September, 2022. The study was approved by Shenzhen People's Hospital and informed consent was signed
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Denosumab Only Product | denosumab subcutaneous injection /6 months, twice a year |
Timeline
- Start date
- 2021-09-14
- Primary completion
- 2023-03-20
- Completion
- 2023-09-25
- First posted
- 2021-10-01
- Last updated
- 2023-03-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05065164. Inclusion in this directory is not an endorsement.